![Man ultramarathon runner in the mountains he trains at sunset](https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/0B4B1380-42EB-4FD5-9D7E2DBC603E79F8/webimage-C4875379-1478-416F-B03DF68FE3D8DBB5.png)
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Immunol. , 28 May 2021
Sec. Alloimmunity and Transplantation
Volume 12 - 2021 | https://doi.org/10.3389/fimmu.2021.656242
This article is part of the Research Topic New Insights into and Interventions of the Persistent Immune Responses in Chronic Graft Rejection View all 18 articles
A retraction of this article was approved in:
Retraction: Curcumin Blunts IL-6 Dependent Endothelial‐to‐Mesenchymal Transition to Alleviate Renal Allograft Fibrosis Through Autophagy Activation
Citation: Zhou J, Yao M, Zhu M, Li M, Ke Q, Wu B and Wang D (2021) Curcumin Blunts IL-6 Dependent Endothelial‐to‐Mesenchymal Transition to Alleviate Renal Allograft Fibrosis Through Autophagy Activation. Front. Immunol. 12:656242. doi: 10.3389/fimmu.2021.656242
Received: 20 January 2021; Accepted: 10 May 2021;
Published: 28 May 2021; Retracted: 26 November 2021.
Edited by:
Hao Wang, Tianjin Medical University General Hospital, ChinaReviewed by:
Peixiang Lan, Huazhong University of Science and Technology, ChinaDisclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.